Author

E. M. Deltcheva

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Assay:ChIP-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Illendula· 1 shared C. Boiers· 1 shared H. H. Stunnenberg· 1 shared J. B. Chhetri· 1 shared J. H. Bushweller· 1 shared J. H. Martens· 1 shared J. P. Wray· 1 shared R. Nimmo· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Illendula

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cell cycle corruption in a preleukemic ETV6-RUNX1 model exposes RUNX1 addiction as a therapeutic target in acute lymphoblastic leukemia

J. P. Wray, E. M. Deltcheva, C. Boiers, S. E. Richardson, J. B. Chhetri, S. Gagrica, Y. Guo, A. Illendula, J. H. Martens, H. H. Stunnenberg, J. H. Bushweller, R. Nimmo, T. Enver

This study shows that RUNX1 addiction is a therapeutic target in acute lymphoblastic leukemia, as inhibiting RUNX1 activity spares normal hematopoiesis and affects multiple genetic subtypes.

bioRxiv · Dec 22, 2020 · PreprintCancer Biology